Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Pain and self-reported swollen joints are main drivers of patient-reported flares in rheumatoid arthritis. Results from a 12-months' observational study.

Kuettel D, Primdahl J, Weber U, Terslev L, Østergaard M, Petersen R, Pedersen AK, Möller S, Hørslev-Petersen K.

J Rheumatol. 2019 Dec 1. pii: jrheum.190760. doi: 10.3899/jrheum.190760. [Epub ahead of print]

PMID:
31787604
2.

Interactions between women with rheumatoid arthritis and nurses during outpatient consultations: A qualitative study.

Feddersen H, Kristiansen TM, Andersen PT, Hørslev-Petersen K, Primdahl J.

Musculoskeletal Care. 2019 Nov 27. doi: 10.1002/msc.1435. [Epub ahead of print]

PMID:
31777181
3.

Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity.

Issa SF, Lindegaard HM, Lorenzen T, Junker K, Christensen AF, Hørslev-Petersen K, Holmskov U, Sorensen GL, Junker P.

Clin Exp Rheumatol. 2019 Aug 27. [Epub ahead of print]

PMID:
31498068
4.

Flares in rheumatoid arthritis: do patient-reported swollen and tender joints match clinical and ultrasonography findings?

Kuettel D, Terslev L, Weber U, Østergaard M, Primdahl J, Petersen R, Ammitzbøll-Danielsen M, Möller S, Hørslev-Petersen K.

Rheumatology (Oxford). 2019 Jun 25. pii: kez231. doi: 10.1093/rheumatology/kez231. [Epub ahead of print]

PMID:
31382292
5.

A parametric study of effect of experimental tibialis posterior muscle pain on joint loading and muscle forces-Implications for patients with rheumatoid arthritis?

Simonsen MB, Yurtsever A, Næsborg-Andersen K, Leutscher PDC, Hørslev-Petersen K, Hirata RP, Andersen MS.

Gait Posture. 2019 Jul;72:102-108. doi: 10.1016/j.gaitpost.2019.06.001. Epub 2019 Jun 5.

PMID:
31185371
6.

Tibialis posterior muscle pain effects on hip, knee and ankle gait mechanics.

Simonsen MB, Yurtsever A, Næsborg-Andersen K, Leutscher PDC, Hørslev-Petersen K, Andersen MS, Hirata RP.

Hum Mov Sci. 2019 Apr 10;66:98-108. doi: 10.1016/j.humov.2019.04.002. [Epub ahead of print]

PMID:
30981150
7.

Brugerinddragelse i forskning. Need to have or nice to have?

Hørslev-Petersen K.

Ugeskr Laeger. 2019 Mar 4;181(10). pii: V70262. Danish. No abstract available.

PMID:
30869067
8.

Validity and Responsiveness of Combined Inflammation and Combined Joint Damage Scores Based on the OMERACT Rheumatoid Arthritis MRI Scoring System (RAMRIS).

Sundin U, Østergaard M, Glinatsi D, Aga AB, Hørslev-Petersen K, Hetland ML, Stengard-Pedersen K, Junker P, Ejbjerg BJ, Bird P, Conaghan PG, Lillegraven S, Haavardsholm EA.

J Rheumatol. 2019 Sep;46(9):1222-1227. doi: 10.3899/jrheum.181064. Epub 2019 Feb 15.

PMID:
30770509
9.

Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.

Møller-Bisgaard S, Hørslev-Petersen K, Ejbjerg B, Hetland ML, Ørnbjerg LM, Glinatsi D, Møller J, Boesen M, Christensen R, Stengaard-Pedersen K, Madsen OR, Jensen B, Villadsen JA, Hauge EM, Bennett P, Hendricks O, Asmussen K, Kowalski M, Lindegaard H, Nielsen SM, Bliddal H, Krogh NS, Ellingsen T, Nielsen AH, Balding L, Jurik AG, Thomsen HS, Østergaard M.

JAMA. 2019 Feb 5;321(5):461-472. doi: 10.1001/jama.2018.21362.

10.

'Isn't biological treatment something healthy?' Lay people's perceptions of medical terms.

Christiansen AA, Hendricks RC, Primdahl J, Roessler KK, Andersen TE, Hørslev-Petersen K, Hendricks O.

Scand J Rheumatol. 2019 May;48(3):253-255. doi: 10.1080/03009742.2018.1522667. Epub 2018 Nov 13. No abstract available.

PMID:
30422729
11.

Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years' functional and radiographic outcome in early rheumatoid arthritis.

Hetland ML, Østergaard M, Stengaard-Pedersen K, Junker P, Ejbjerg B, Jacobsen S, Ellingsen T, Lindegaard H, Pødenphant J, Vestergaard A, Jurik AG, Krogh NS, Hørslev-Petersen K; and The CIMESTRA Study Group*.

Scand J Rheumatol. 2019 Jan;48(1):1-8. doi: 10.1080/03009742.2018.1466362. Epub 2018 Aug 13.

PMID:
30101636
12.

The D-vitamin metabolite 1,25(OH)2 D in serum is associated with disease activity and Anti-Citrullinated Protein Antibodies in active and treatment naïve, early Rheumatoid Arthritis Patients.

Herly M, Stengaard-Pedersen K, Vestergaard P, Østergaard M, Junker P, Hetland ML, Hørslev-Petersen K, Ellingsen T.

Scand J Immunol. 2018 Sep;88(3):e12704. doi: 10.1111/sji.12704. Epub 2018 Aug 22.

13.

Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial.

Brahe CH, Østergaard M, Johansen JS, Defranoux N, Wang X, Bolce R, Sasso EH, Ørnbjerg LM, Hørslev-Petersen K, Stengaard-Pedersen K, Junker P, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Schlemmer A, Dam MY, Hansen I, Lottenburger T, Ammitzbøll C, Jørgensen A, Krintel SB, Raun J, Hetland ML.

Scand J Rheumatol. 2019 Jan;48(1):9-16. doi: 10.1080/03009742.2018.1464206. Epub 2018 Jul 9.

PMID:
29985080
14.

Mortality and its predictors in patients with rheumatoid arthritis: a Danish population-based inception cohort study.

Pedersen JK, Holst R, Primdahl J, Svendsen AJ, Hørslev-Petersen K.

Scand J Rheumatol. 2018 Sep;47(5):371-377. doi: 10.1080/03009742.2017.1420223. Epub 2018 May 9.

PMID:
29741136
15.

Juggling identities of rheumatoid arthritis, motherhood and paid work - a grounded theory study.

Feddersen H, Mechlenborg Kristiansen T, Tanggaard Andersen P, Hørslev-Petersen K, Primdahl J.

Disabil Rehabil. 2019 Jun;41(13):1536-1544. doi: 10.1080/09638288.2018.1433723. Epub 2018 Feb 1.

PMID:
29390903
16.

Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation studies based on the CIMESTRA and OPERA trials.

Brahe CH, Dehlendorff C, Østergaard M, Johansen JS, Ørnbjerg LM, Hørslev-Petersen K, Stengaard-Pedersen K, Junker P, Ellingsen T, Lindegaard H, Hansen I, Lottenburger T, Jacobsen S, Jurik AG, Hetland ML.

Scand J Rheumatol. 2018 Jul;47(4):259-269. doi: 10.1080/03009742.2017.1376107. Epub 2018 Jan 16.

PMID:
29336711
17.

Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical Trial.

Sode J, Krintel SB, Carlsen AL, Hetland ML, Johansen JS, Hørslev-Petersen K, Stengaard-Pedersen K, Ellingsen T, Burton M, Junker P, Østergaard M, Heegaard NHH.

J Rheumatol. 2018 Jan;45(1):53-61. doi: 10.3899/jrheum.170266. Epub 2017 Nov 15.

PMID:
29142030
18.

Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity.

Issa SF, Christensen AF, Lindegaard HM, Hetland ML, Hørslev-Petersen K, Stengaard-Pedersen K, Ejbjerg BJ, Lottenburger T, Ellingsen T, Pedersen JK, Junker K, Svendsen A, Tarp U, Østergaard M, Junker P.

Scand J Immunol. 2017 Dec;86(6):471-478. doi: 10.1111/sji.12619. Epub 2017 Nov 1.

19.

Impact of patient-reported flares on radiographic progression and functional impairment in patients with rheumatoid arthritis: a cohort study based on the AMBRA trial.

Kuettel D, Primdahl J, Christensen R, Ørnbjerg LM, Hørslev-Petersen K.

Scand J Rheumatol. 2018 Mar;47(2):87-94. doi: 10.1080/03009742.2017.1329457. Epub 2017 Aug 25.

PMID:
28841103
20.

Construction of meaningful identities in the context of rheumatoid arthritis, motherhood and paid work: A meta-ethnography.

Feddersen H, Kristiansen TM, Andersen PT, Hørslev-Petersen K, Primdahl J.

J Clin Nurs. 2017 Dec;26(23-24):4117-4128. doi: 10.1111/jocn.13940. Epub 2017 Sep 4. Review.

PMID:
28639276
21.

Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trials.

Glinatsi D, Baker JF, Hetland ML, Hørslev-Petersen K, Ejbjerg BJ, Stengaard-Pedersen K, Junker P, Ellingsen T, Lindegaard HM, Hansen I, Lottenburger T, Møller JM, Ørnbjerg L, Vestergaard A, Jurik AG, Thomsen HS, Torfing T, Møller-Bisgaard S, Axelsen MB, Østergaard M.

Ann Rheum Dis. 2017 Oct;76(10):1707-1715. doi: 10.1136/annrheumdis-2017-211315. Epub 2017 Jun 13.

PMID:
28611080
22.

Soluble CD206 plasma levels in rheumatoid arthritis reflect decrease in disease activity.

Heftdal LD, Stengaard-Pedersen K, Ørnbjerg LM, Hetland ML, Hørslev-Petersen K, Junker P, Østergaard M, Hvid M, Deleuran B, Møller HJ, Greisen SR.

Scand J Clin Lab Invest. 2017 Sep;77(5):385-389. doi: 10.1080/00365513.2017.1331462. Epub 2017 Jun 9.

PMID:
28598681
23.

Hepcidin plasma levels are not associated with changes in haemoglobin in early rheumatoid arthritis patients.

Østgård RD, Glerup H, Jurik AG, Kragstrup TW, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Junker P, Deleuran BW.

Scand J Rheumatol. 2017 Nov;46(6):441-445. doi: 10.1080/03009742.2017.1286382. Epub 2017 May 9.

PMID:
28482738
24.

Increased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis subsets.

Issa SF, Duer A, Østergaard M, Hørslev-Petersen K, Hetland ML, Hansen MS, Junker K, Lindegaard HM, Møller JM, Junker P.

Arthritis Res Ther. 2017 Apr 26;19(1):80. doi: 10.1186/s13075-017-1282-4.

25.

Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes.

Herly M, Stengaard-Pedersen K, Hørslev-Petersen K, Hetland ML, Østergaard M, Christensen R, Løgstrup BB, Vestergaard P, Pødenphant J, Junker P, Ellingsen T.

BMJ Open. 2017 Apr 8;7(4):e014816. doi: 10.1136/bmjopen-2016-014816.

26.

Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: study protocol for a multicenter, randomized, open-label, blinded-assessor, phase 4 study.

Glinatsi D, Heiberg MS, Rudin A, Nordström D, Haavardsholm EA, Gudbjornsson B, Østergaard M, Uhlig T, Grondal G, Hørslev-Petersen K, van Vollenhoven R, Hetland ML.

Trials. 2017 Apr 4;18(1):161. doi: 10.1186/s13063-017-1891-x.

27.

Expression of soluble CD83 in plasma from early-stage rheumatoid arthritis patients is not modified by anti-TNF-α therapy.

Kristensen AM, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Junker P, Østergaard M, Höllsberg P, Deleuran B, Hvid M.

Cytokine. 2017 Aug;96:1-7. doi: 10.1016/j.cyto.2017.02.017. Epub 2017 Mar 6.

PMID:
28267648
28.

Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.

Ørnbjerg LM, Østergaard M, Jensen T, Hørslev-Petersen K, Stengaard-Pedersen K, Junker P, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Schlemmer A, Dam MY, Hansen I, Lottenburger T, Ammitzbøll CG, Jørgensen A, Krintel SB, Raun J, Hetland ML; OPERA Study Group, Slot O, Nielsen LK, Skjødt H, Majgaard O, Lorenzen T, Horn HC, Kowalski M, Johansen IL, Pedersen PM, Manilo N, Bliddal H.

Clin Rheumatol. 2017 Apr;36(4):781-789. doi: 10.1007/s10067-016-3489-1. Epub 2016 Dec 5.

PMID:
27921185
29.

Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study.

Nissen CB, Hørslev-Petersen K, Primdahl J.

Rheumatol Int. 2017 Jan;37(1):113-120. doi: 10.1007/s00296-016-3614-0. Epub 2016 Nov 26.

PMID:
27889826
30.

Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA).

Møller-Bisgaard S, Ejbjerg BJ, Eshed I, Hørslev-Petersen K, Hetland ML, Jurik AG, Thomsen H, Torfing T, Stengaard-Pedersen K, Junker P, Krogh NS, Lottenburger T, Ellingsen T, Andersen LS, Skjødt H, Svendsen AJ, Tarp U, Hansen IT, Pødenphant J, Pedersen JK, Lindegaard H, Hanson LG, Vestergaard A, Glinatsi D, Østergaard M.

Scand J Rheumatol. 2017 Sep;46(5):335-345. doi: 10.1080/03009742.2016.1209550. Epub 2016 Oct 24.

PMID:
27775461
31.

Limited Reliability of Radiographic Assessment of Sacroiliac Joints in Patients with Suspected Early Spondyloarthritis.

Christiansen AA, Hendricks O, Kuettel D, Hørslev-Petersen K, Jurik AG, Nielsen S, Rufibach K, Loft AG, Pedersen SJ, Hermansen LT, Østergaard M, Arnbak B, Manniche C, Weber U.

J Rheumatol. 2017 Jan;44(1):70-77. doi: 10.3899/jrheum.160079. Epub 2016 Oct 15.

PMID:
27744397
32.

Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis: new developments from the DANBIO registry.

Hetland ML, Krogh NS, Hørslev-Petersen K, Schiøttz-Christensen B, Sørensen IJ, Dorte Vendelbo J.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5 Suppl 101):S75-S78. Epub 2016 Oct 19.

33.

No diagnostic utility of antibody patterns against Klebsiella pneumoniae capsular serotypes in patients with axial spondyloarthritis vs. patients with non-specific low back pain: a cross-sectional study.

Hermansen LT, Loft AG, Christiansen AA, Munk HL, Gilbert L, Jurik AG, Arnbak B, Manniche C, Weber U, Østergaard M, Pedersen SJ, Barington T, Junker P, Hørslev-Petersen K, Hendricks O.

Scand J Rheumatol. 2017 Jul;46(4):296-302. doi: 10.1080/03009742.2016.1205659. Epub 2016 Sep 7.

PMID:
27600931
34.

A disintegrin and metalloprotease-17 and galectin-9 are important regulators of local 4-1BB activity and disease outcome in rheumatoid arthritis.

Nielsen MA, Andersen T, Etzerodt A, Kragstrup TW, Rasmussen TK, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Junker P, Østergaard M, Hvid M, Moestrup SK, Deleuran B.

Rheumatology (Oxford). 2016 Oct;55(10):1871-9. doi: 10.1093/rheumatology/kew237. Epub 2016 Jun 21.

PMID:
27330157
35.

Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial.

Svensson AL, Christensen R, Persson F, Løgstrup BB, Giraldi A, Graugaard C, Fredberg U, Blegvad J, Thygesen T, Hansen IM, Colic A, Bagdat D, Ahlquist P, Jensen HS, Hørslev-Petersen K, Sheetal E, Christensen TG, Svendsen L, Emmertsen H, Ellingsen T.

BMJ Open. 2016 Apr 20;6(4):e009134. doi: 10.1136/bmjopen-2015-009134.

36.

The discriminative value of inflammatory back pain in patients with persistent low back pain.

Arnbak B, Hendricks O, Hørslev-Petersen K, Jurik AG, Pedersen SJ, Østergaard M, Hermansen LT, Loft AG, Jensen TS, Manniche C.

Scand J Rheumatol. 2016 Jul;45(4):321-8. doi: 10.3109/03009742.2015.1105289. Epub 2016 Mar 16.

PMID:
26982485
37.

The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression.

Kragstrup TW, Greisen SR, Nielsen MA, Rhodes C, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Junker P, Østergaard M, Hvid M, Vorup-Jensen T, Robinson WH, Sokolove J, Deleuran B.

Arthritis Res Ther. 2016 Mar 11;18:61. doi: 10.1186/s13075-016-0964-7.

38.

Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response.

Kragstrup TW, Jalilian B, Keller KK, Zhang X, Laustsen JK, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Junker P, Østergaard M, Hauge EM, Hvid M, Vorup-Jensen T, Deleuran B.

PLoS One. 2016 Feb 5;11(2):e0148486. doi: 10.1371/journal.pone.0148486. eCollection 2016.

39.

Associations Between Spondyloarthritis Features and Magnetic Resonance Imaging Findings: A Cross-Sectional Analysis of 1,020 Patients With Persistent Low Back Pain.

Arnbak B, Grethe Jurik A, Hørslev-Petersen K, Hendricks O, Hermansen LT, Loft AG, Østergaard M, Pedersen SJ, Zejden A, Egund N, Holst R, Manniche C, Jensen TS.

Arthritis Rheumatol. 2016 Apr;68(4):892-900. doi: 10.1002/art.39551.

40.

Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA).

Hørslev-Petersen K, Hetland ML, Ørnbjerg LM, Junker P, Pødenphant J, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Schlemmer A, Dam MY, Hansen I, Lottenburger T, Ammitzbøll CG, Jørgensen A, Krintel SB, Raun J, Johansen JS, Østergaard M, Stengaard-Pedersen K; OPERA Study-Group.

Ann Rheum Dis. 2016 Sep;75(9):1645-53. doi: 10.1136/annrheumdis-2015-208166. Epub 2015 Oct 21.

PMID:
26489704
41.

Prevalence of degenerative and spondyloarthritis-related magnetic resonance imaging findings in the spine and sacroiliac joints in patients with persistent low back pain.

Arnbak B, Jensen TS, Egund N, Zejden A, Hørslev-Petersen K, Manniche C, Jurik AG.

Eur Radiol. 2016 Apr;26(4):1191-203. doi: 10.1007/s00330-015-3903-0. Epub 2015 Jul 22.

PMID:
26194456
42.

Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci.

Nexø BA, Villesen P, Nissen KK, Lindegaard HM, Rossing P, Petersen T, Tarnow L, Hansen B, Lorenzen T, Hørslev-Petersen K, Jensen SB, Bahrami S, Lajer M, Schmidt KL, Parving HH, Junker P, Laska MJ.

Immunol Res. 2016 Feb;64(1):55-63. doi: 10.1007/s12026-015-8671-z.

43.

Interleukin-23 in early disease development in rheumatoid arthritis.

Andersen T, Hvid M, Johansen C, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Junker P, Østergaard M, Deleuran B.

Scand J Rheumatol. 2015;44(6):438-42.

PMID:
26087654
44.

Diagnostic Delay in Rheumatoid Arthritis: A Qualitative Study of Symptom Interpretation Before the First Visit to the Doctor.

Mølbaek K, Hørslev-Petersen K, Primdahl J.

Musculoskeletal Care. 2016 Mar;14(1):26-36. doi: 10.1002/msc.1108. Epub 2015 Jun 5.

PMID:
26052985
45.

Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs.

Greisen SR, Møller HJ, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Junker P, Østergaard M, Hvid M, Deleuran B.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4):498-502. Epub 2015 May 11.

PMID:
25962601
46.

Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis.

Krintel SB, Dehlendorff C, Hetland ML, Hørslev-Petersen K, Andersen KK, Junker P, Pødenphant J, Ellingsen T, Ahlquist P, Lindegaard HM, Linauskas A, Schlemmer A, Dam MY, Hansen I, Horn HC, Jørgensen A, Raun J, Ammitzbøll CG, Østergaard M, Stengaard-Pedersen K, Johansen JS.

Pharmacogenomics J. 2016 Apr;16(2):141-6. doi: 10.1038/tpj.2015.30. Epub 2015 May 5.

PMID:
25939484
47.

Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial.

Møller-Bisgaard S, Hørslev-Petersen K, Ejbjerg BJ, Boesen M, Hetland ML, Christensen R, Møller J, Krogh NS, Stengaard-Pedersen K, Østergaard M.

Trials. 2015 Apr 21;16:178. doi: 10.1186/s13063-015-0693-2.

48.

Within-day variation and influence of physical exercise on circulating Galectin-3 in patients with rheumatoid arthritis and healthy individuals.

Issa SF, Christensen AF, Lottenburger T, Junker K, Lindegaard H, Hørslev-Petersen K, Junker P.

Scand J Immunol. 2015 Jul;82(1):70-5. doi: 10.1111/sji.12301.

49.

Shared care or nurse consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis (RA) outpatients with stable low disease-activity RA: cost-effectiveness based on a 2-year randomized trial.

Sørensen J, Primdahl J, Horn HC, Hørslev-Petersen K.

Scand J Rheumatol. 2015;44(1):13-21. doi: 10.3109/03009742.2014.928945. Epub 2014 Nov 7.

PMID:
25380077
50.

CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients.

Ammitzbøll CG, Steffensen R, Bøgsted M, Hørslev-Petersen K, Hetland ML, Junker P, Johansen JS, Pødenphant J, Østergaard M, Ellingsen T, Stengaard-Pedersen K.

Arthritis Res Ther. 2014 Oct 31;16(5):475. doi: 10.1186/s13075-014-0475-3.

Supplemental Content

Loading ...
Support Center